Zevra Therapeutics, Inc. (ZVRA)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
| Application | Product Name | Active Ingredient | Form | Strength | Status | ||
|---|---|---|---|---|---|---|---|
| NDA208653 - ZEVRA THERAP | |||||||
| APADAZ | ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | TABLET;ORAL | 325MG;EQ 6.12MG BASE | Discontinued | |||
| APADAZ | ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | TABLET;ORAL | 325MG;EQ 4.08MG BASE | Discontinued | |||
| APADAZ | ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | TABLET;ORAL | 325MG;EQ 8.16MG BASE | Discontinued | |||